All ProductsDisplaying Products Alphabetically by Name (T)
| Cat. No. | Product Name / Activity |
|---|---|
| 2373 | T 0901317 |
| Potent liver X receptor (LXR) agonist; also CAR inverse agonist | |
| 7690 | T 112 |
| Estrogen-related receptor γ agonist; promotes maturation of hiPSC-derived cardiomyocytes | |
| 6106 | T 3364366 |
| Potent and reversible fatty acid desaturase 1 inhibitor; orally bioavailable | |
| 7317 | T 5224 |
| Selective inhibitor of c-Fos/activator protein (AP)-1 | |
| 2301 | T 0070907 |
| Highly potent and selective covalent PPARγ antagonist | |
| 6666 | T3 |
| Thyroid hormone; also promotes differentiation of oligodendroglial precursor cells | |
| 7570 | T3 CLK |
| Potent and selective pan-CLK inhibitor; also inhibits DYRK1A/B | |
| TB6666-RMU | T3 |
| T3 synthesized to Ancillary Material Grade | |
| 7054 | T4 |
| Modulator of alternative polyadenylation; inhibits rod photoreceptor gene expression via Nr2e3 | |
| 8825 | TAC |
| TERT activator | |
| 3599 | TAK 165 |
| Potent and selective ErbB2 inhibitor | |
| 5209 | TAK 21d |
| Potent FAAH inhibitor | |
| 6587 | TAK 242 |
| TLR4 signaling inhibitor | |
| 6777 | TAK 375 |
| Very high affinity and selective melatonin receptor agonist | |
| 4254 | TAK 715 |
| Potent p38 MAPK inhibitor; anti-inflammatory | |
| 4340 | TAK 779 |
| Potent and selective CCR5 and CCR2 chemokine receptor antagonist | |
| 5403 | TAK 960 hydrochloride |
| Potent and selective PLK1 inhibitor | |
| 5523 | TAPI 0 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6162 | TAPI 1 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6013 | TAPI 2 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6498 | TASP 0277308 |
| Potent and selective S1P1 receptor antagonist; inhibits angiogenesis | |
| 5729 | TASP 0390325 |
| Potent and selective V1B receptor antagonist; orally bioavailable | |
| 5362 | TASP 0433864 |
| Selective positive allosteric modulator of mGlu2 receptors | |
| 6227 | TAT-Gap19 |
| Cx43 hemichannel blocker | |
| 7402 | TAT-Gap19(I130A) |
| Control peptide for TAT-Gap19 | |
| 7832 | TAT-PDHPS1 |
| YAP inhibitor | |
| 7962 | TAT-SAMβA Peptide |
| Selective antagonist of Mfn1-βIIPKC association | |
| 2905 | TB 21007 |
| α5-selective GABAA inverse agonist | |
| 2275 | TBB |
| Selective cell-permeable CK2 inhibitor | |
| 7660 | TBI |
| Fluorogenic ligand for Broccoli RNA aptamer | |
| 7259 | TBK1 PROTAC® 3i |
| Potent TANK-binding kinase 1 (TBK1) PROTAC® | |
| 7260 | TBK1 control PROTAC® 4 |
| Negative control for TBK1 PROTAC® 3i (Cat. No. 7259) | |
| 1223 | DL-TBOA |
| Selective non-transportable inhibitor of EAATs | |
| 7862 | TBTA |
| Click chemistry auxiliary reagent; stabilizing ligand for copper-catalyzed azide-alkyne cycloaddition reaction | |
| 4300 | TC 14012 |
| CXCR4 antagonist; ACKR3 (CXCR7) agonist | |
| 2737 | TC 2559 difumarate |
| Selective α4β2 nAChR partial agonist | |
| 5412 | TC AQP1 1 |
| Aquaporin 1 (AQP1) channel blocker | |
| 4825 | TC ASK 10 |
| Potent and selective ASK1 inhibitor; orally bioavailable | |
| 6125 | TC JL 37 |
| Potent TYK2 inhibitor | |
| 4708 | TC LPA5 4 |
| LPA5 receptor antagonist | |
| 5087 | TC NTR1 17 |
| Selective NTS1 partial agonist | |
| 4625 | TC OT 39 |
| Potent non-peptide oxytocin receptor partial agonist; also V1a receptor antagonist | |
| 6884 | TC SL C5 |
| Metastasis-associated lung adenocarcinoma transcript 1 (Malat1) RNA inhibitor | |
| 4066 | TC-A 2317 hydrochloride |
| Potent, selective Aurora kinase A inhibitor | |
| 4301 | TC-DAPK 6 |
| Potent and selective inhibitor of DAPK1 | |
| 5089 | TC-E 5002 |
| Selective KDM2/7 inhibitor | |
| 4355 | TC-F 2 |
| Potent, reversible and selective FAAH inhibitor | |
| 4624 | TC-FPR 43 |
| Potent FPR2 agonist | |
| 4879 | TC-G 1001 |
| GPR35 agonist; more potent than zaprinast (Cat. No. 0947) | |
| 4407 | TC-G 1004 |
| Potent and selective A2A antagonist | |
| 5129 | TC-G 1005 |
| Potent and selective GPBA receptor (TGR5) agonist | |
| 5355 | TC-G 1008 |
| Potent and selective GPR39 agonist | |
| 4353 | TC-G 24 |
| Potent and selective GSK-3β inhibitor | |
| 4527 | TC-I 15 |
| Potent α2β1 inhibitor; displays antithrombotic activity in vivo | |
| 4632 | TC-I 2000 |
| TRPM8 blocker | |
| 5410 | TC-I 2014 |
| Potent TRPM8 antagonist | |
| 4365 | TC-MCH 7c |
| Selective melanin-concentrating hormone receptor 1 (MCH1R) antagonist | |
| 4435 | TC-N 1752 |
| NaV channel blocker | |
| 4961 | TC-S 7001 |
| Potent and highly selective ROCK inhibitor; orally active | |
| 3567 | TC-S 7003 |
| Potent Lck inhibitor | |
| 5088 | TC-S 7004 |
| Potent and selective DYRK1A/B inhibitor | |
| 4459 | TC-S 7005 |
| Potent and selective PLK2 inhibitor | |
| 5240 | TC-S 7006 |
| Potent and selective Tpl2 (Cot; MAP3K8) inhibitor | |
| 5243 | TC-S 7009 |
| High affinity and selective HIF-2α inhibitor | |
| 2592 | TCB-2 |
| High affinity and potent 5-HT2A agonist | |
| 7489 | TCH-165 |
| Enhancer of 20S proteasome assembly and 20S-mediated protein degradation | |
| 4154 | TCN 201 |
| GluN1/GluN2A-selective NMDA antagonist | |
| 3818 | TCS 1102 |
| Potent, dual orexin receptor antagonist | |
| 3869 | TCS 2002 |
| Potent GSK-3β inhibitor | |
| 3900 | TCS 2314 |
| α4β1 (VLA-4) antagonist | |
| 4069 | TCS 2510 |
| Selective EP4 agonist | |
| 2591 | TCS 359 |
| Potent FLT3 inhibitor | |
| 4465 | TCS ERK 11e |
| Potent and selective ERK2 inhibitor | |
| 2827 | TCS JNK 5a |
| Selective inhibitor of JNK2 and JNK3 | |
| 3222 | TCS JNK 6o |
| Selective JNK inhibitor | |
| TB3222-RMU | TCS JNK 6o |
| TCS JNK 6o synthesized to Ancillary Material Grade | |
| 3371 | TCS OX2 29 |
| Potent and selective OX2 antagonist | |
| 2979 | TCS PIM-1 1 |
| Selective, ATP-competitive Pim-1 kinase inhibitor | |
| 8036 | TDI 11861 |
| Soluble adenylyl cyclase inhibitor | |
| 6092 | TDZD 8 |
| Selective non-ATP competitive inhibitor of GSK 3β | |
| 7809 | TEPP 46 |
| Potent and selective pyruvate kinase M2 (PKM2) allosteric activator | |
| 2532 | TFB-TBOA |
| Potent and selective EAAT1 and EAAT2 blocker | |
| 5108 | TFC 007 |
| Potent hematopoietic prostaglandin D synthase (H-PGDS) inhibitor | |
| 1464 | TFLLR-NH2 |
| PAR1-activating peptide | |
| 3813 | TFM-4AS-1 |
| Selective androgen receptor modulator (SARM) | |
| 7742 | TFRGAP-NH2 |
| PAR3 peptide agonist | |
| 4336 | TG 003 |
| Potent inhibitor of Clk-family kinases; also inhibits DYRK1A/B | |
| 5425 | TGN 020 |
| Aquaporin 4 (AQP4) channel blocker | |
| 7778 | TH 10785 |
| OGG1 activator | |
| 7422 | TH 1760 |
| Potent and selective NUDT15 hydrolase inhibitor | |
| 6534 | TH 5427 hydrochloride |
| Potent NUDT5 inhibitor | |
| 7719 | TH 9619 disodium salt |
| MTHFD2 inhibitor | |
| 6532 | THAL SNS 032 |
| Potent and selective Cdk9 Degrader (PROTAC®) | |
| 1990 | (R,R)-THC |
| Potent subtype-selective ligand; ERα agonist/ERβ antagonist | |
| 6334 | THDOC |
| Positive modulator of GABAA receptors; endogenous neurosteroid | |
| 0807 | THIP hydrochloride |
| GABAA agonist | |
| 3032 | THIQ |
| Potent and selective MC4 receptor agonist | |
| 7863 | THPTA |
| Click chemistry auxiliary reagent; accelerating ligand for copper-catalyzed azide-alkyne cycloaddition reaction | |
| 6981 | TL 0259 |
| Selective and highly potent Fgr and Lyn kinase inhibitor; orally bioavailable | |
| 6524 | TL 12-186 |
| Multikinase Degrader (PROTAC®) | |
| 6746 | TL 13-110 |
| Negative control for TL 13-112 (Cat. No. 6745) | |
| 6745 | TL 13-112 |
| Selective ALK Degrader (PROTAC®) | |
| 6744 | TL 13-12 |
| Selective ALK Degrader (PROTAC®) | |
| 6747 | TL 13-22 |
| Negative control for TL 13-12 (Cat. No. 6744) | |
| 6525 | TL 13-27 |
| Negative control for TL 12-186 (Cat. No. 6524) | |
| 5910 | TL4-12 |
| Potent MAP4K2 (GCK) inhibitor | |
| 3051 | TLQP 21 |
| VGF-derived peptide | |
| 7131 | TM 38837 |
| Highly potent CB1 inverse agonist; peripherally restricted | |
| 5769 | TM 5275 sodium salt |
| Plasminogen activator inhibitor-1 (PAI-1) inhibitor; orally bioavailable | |
| 6194 | TM 5441 |
| Plasminogen activator inhibitor-1 (PAI-1) inhibitor | |
| 7917 | TM2 TEAD inhibitor |
| Potent and reversible inhibitor of TEAD mediated Hippo/Yap signalling | |
| 5960 | TMI 1 |
| Adam 17 (TACE) and MMP inhibitor; orally bioavailable | |
| 4253 | TMPyP4 tosylate |
| Inhibitor of human telomerase | |
| 6802 | 6 TMR Tre |
| Fluorescent trehalose; selectively labels mycobacterial cell envelope | |
| 2464 | TNP-ATP triethylammonium salt |
| Potent and selective P2X antagonist | |
| 4414 | TP 003 |
| GABAA partial agonist; acts at benzodiazepine site | |
| 6008 | TP 064 |
| Potent and selective PRMT 4 inhibitor | |
| 6670 | TP 238 |
| CECR2 and BPTF/FALZ inhibitor | |
| 6000 | TP 472 |
| Potent BRD9/7 inhibitor | |
| 5999 | TP 472N |
| Negative control for TP 472 | |
| 7771 | TP-040 |
| Potent and selective O-GlcNAcase (OGA) inhibitor | |
| 2559 | TPCA-1 |
| Potent, selective inhibitor of IKKβ | |
| 4309 | TPEN |
| Cell-permeable Zn2+ chelator; also inhibits RNA binding protein Lin28 | |
| 1040 | TPMPA |
| Selective GABAA-ρ antagonist | |
| 5343 | TPPB |
| High affinity PKC activator; also APP modulator | |
| 6908 | TR 14035 |
| Potent integrin α4β7 and α4β1 (VLA-4) antagonist; orally bioavailable | |
| 8121 | TRAM 1 |
| Chemical inducer of proximity for dTAG protein FKBPF36V and ecDHFR tags | |
| 2946 | TRAM 34 |
| Potent and highly selective KCa3.1 (IK) channel blocker | |
| 3497 | TRAP-6 |
| PAR1 peptide fragment (residues 42-47); acts as a PAR1 agonist | |
| 3163 | TRIS base |
| Commonly used laboratory reagent; used to make TBS, TAE and TBE buffers | |
| 2906 | TRO 19622 |
| Binds voltage-dependent anion channel (VDAC) | |
| 6875 | TRPC6-PAM-C20 |
| Selective positive allosteric modulator (PAM) of TRPC6 | |
| 6831 | TRPV3 74a |
| Selective TRPV3 antagonist; brain penetrant | |
| 7523 | TSA Vivid™ Fluorophore Kit 520 |
| Signal amplification kit for use in ISH, ICC and IHC | |
| 7526 | TSA Vivid™ Fluorophore Kit 570 |
| Signal amplification kit for use in ISH, ICC and IHC | |
| 7527 | TSA Vivid™ Fluorophore Kit 650 |
| Signal amplification kit for use in ISH, ICC and IHC | |
| 0761 | TTNPB |
| Retinoic acid analog; RAR agonist | |
| 4432 | TTP 22 |
| High affinity, selective CK2 inhibitor | |
| 4601 | TUG 891 |
| Potent and selective FFA4 (GPR120) agonist | |
| 7405 | TWS 119 |
| Potent GSK3 inhibitor; induces neuronal and CD8(+) T cell differentiation | |
| 5328 | TY 52156 |
| S1P3 receptor antagonist | |
| 2308 | Tabimorelin hemifumarate |
| Potent, orally active ghrelin receptor agonist | |
| 6311 | Tadalafil |
| Potent and highly selective PDE5 inhibitor; orally bioavailable | |
| 6430 | Takinib |
| Potent and selective TAK1/MAP3K7 kinase inhibitor | |
| 3719 | Talabostat mesylate |
| Potent DPP IV inhibitor; activates NLRP1b inflammasome | |
| 5032 | Talampanel |
| Non-competitive non-NMDA iGluR antagonist | |
| 6342 | Tamoxifen |
| Estrogen receptor partial agonist/antagonist | |
| 0999 | Tamoxifen citrate |
| Estrogen receptor partial agonist/antagonist | |
| 3050 | Tamsulosin hydrochloride |
| Selective α1A antagonist | |
| 2854 | Tandospirone hydrochloride |
| Selective 5-HT1A partial agonist | |
| 5757 | Tariquidar dihydrochloride |
| Potent P-glycoprotein (P-gp) inhibitor | |
| 7493 | Tasimelteon |
| Selective dual melatonin receptor (MT1/MT2) agonist | |
| 7051 | Tasquinimod |
| High affinity HDAC4 negative allosteric modulator; also binds S100A9; antiangiogenic | |
| 1097 | Taxol |
| Promotes assembly and inhibits disassembly of microtubules | |
| 7315 | Taxol Janelia Fluor® 526 |
| Green-fluorescent taxol derivative; binds microtubules. Used for: microtubules imaging. Application: confocal microscopy, super resolution microscopy. Suitable for live cell imaging | |
| 6267 | Taxol Janelia Fluor® 549 |
| Yellow-fluorescent taxol derivative. Used for: microtubule staining. Application: flow cytometry, confocal microscopy, super resolution microscopy | |
| 6266 | Taxol Janelia Fluor® 646 |
| Red-fluorescent taxol derivative. Used for: microtubule staining. Application: confocal microscopy, fluorescence microscopy; protocol available | |
| 8093 | Tazemetostat |
| Potent and selective EZH2 inhibitor | |
| 1122 | Telenzepine dihydrochloride |
| Potent, selective M1 antagonist | |
| 2706 | Temozolomide |
| DNA-methylating antitumor agent | |
| 3082 | Tempol |
| Superoxide scavenger; antioxidant | |
| 5264 | Temsirolimus |
| mTOR inhibitor; antitumor | |
| 6975 | Teniposide |
| DNA topoisomerase II inhibitor; viral transduction enhancer | |
| 3666 | Tenofovir |
| Reverse transcriptase inhibitor | |
| 1506 | Terazosin hydrochloride |
| α1 antagonist; PGK1 activator | |
| 6484 | Terbinafine hydrochloride |
| Selective K2P9.1 (TASK-3) activator; also inhibits fungal squalene epoxidase | |
| 3948 | Terfenadine |
| H1 antagonist. Also KV11.1 (hERG) and Kir6 (KATP) channel blocker | |
| 5069 | Teriflunomide |
| Inhibitor of DHODH; active metabolite of Leflunomide | |
| 1316 | Tertiapin-Q |
| Selective blocker of inward-rectifier K+ channels | |
| 3965 | Tesaglitazar |
| PPARα/γ agonist | |
| 2175 | Tetrabenazine |
| Potent inhibitor of vesicular monoamine transport | |
| 3068 | Tetraethylammonium chloride |
| Non-selective K+ channel blocker | |
| 0312 | (RS)-(Tetrazol-5-yl)glycine |
| Highly potent NMDA agonist | |
| 1078 | Tetrodotoxin |
| Na+ channel blocker | |
| 1069 | Tetrodotoxin citrate |
| Na+ channel blocker; citrate salt of tetrodotoxin (Cat. No. 1078) | |
| 0652 | Thalidomide |
| Binds cereblon; also TNF-α synthesis inhibitor | |
| 7518 | Thalidomide 4'-ether-PEG1-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 6686 | Thalidomide 4'-ether-PEG2-alkyne |
| Cereblon ligand with PEG linker and terminal alkyne for onward chemistry | |
| 7519 | Thalidomide 4'-ether-PEG2-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 6950 | Thalidomide 4'-ether-PEG3-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7520 | Thalidomide 4'-ether-PEG3-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 6951 | Thalidomide 4'-ether-PEG5-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7329 | Thalidomide 4'-ether-alkylC2-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 6850 | Thalidomide 4'-ether-alkylC2-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7330 | Thalidomide 4'-ether-alkylC3-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 7521 | Thalidomide 4'-ether-alkylC3-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7331 | Thalidomide 4'-ether-alkylC4-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 6917 | Thalidomide 4'-ether-alkylC4-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7332 | Thalidomide 4'-ether-alkylC5-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 7522 | Thalidomide 4'-ether-alkylC5-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7333 | Thalidomide 4'-ether-alkylC6-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 6627 | Thalidomide 4'-ether-alkylC6-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7829 | Thalidomide 4'-ether-alkylC6-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7334 | Thalidomide 4'-ether-alkylC7-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 7335 | Thalidomide 4'-ether-alkylC8-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 7403 | Thalidomide 4'-ether-alkylC8-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6966 | Thalidomide 4'-oxyacetamide-PEG1-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 6967 | Thalidomide 4'-oxyacetamide-PEG2-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 6467 | Thalidomide 4'-oxyacetamide-PEG3-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 6913 | Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amine |
| Cereblon ligand with alkyl-PEG-alkyl linker and terminal amine for onward chemistry | |
| 6949 | Thalidomide 4'-oxyacetamide-alkylC2-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6300 | Thalidomide 4'-oxyacetamide-alkylC4-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 6968 | Thalidomide 4'-oxyacetamide-alkylC6-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6946 | Thalidomide 4'-oxyacetamide-alkylC8-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7735 | Thalidomide 5'-amine-PEG1-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7736 | Thalidomide 5'-amine-PEG2-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7737 | Thalidomide 5'-amine-PEG3-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7733 | Thalidomide 5'-amine-alkylC10-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7988 | Thalidomide 5'-amine-alkylC6-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7557 | Thalidomide 5'-amine-alkylC8-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7456 | Thalidomide, 5'-fluoro |
| Fluoro functionalized Thalidomide; cereblon ligand for PROTACs | |
| 6685 | Thalidomide, propargyl |
| Alkyne-functionalized Thalidomide; 'click' cereblon ligand for PROTACs | |
| 6466 | Thalidomide-4-hydroxyacetate |
| Carboxylic acid-functionalized Thalidomide; cereblon ligand for PROTACs | |
| 7288 | Thalidomide-Cyanine 5 |
| High affinity cereblon fluorescent probe | |
| 1138 | Thapsigargin |
| Potent inhibitor of SERCA ATPase | |
| 4390 | Thiamet G |
| Potent O-GlcNAcase inhibitor | |
| 3845 | Thiazovivin |
| ROCK inhibitor; improves the efficiency of fibroblast reprogramming and induction of iPSCs | |
| 3280 | 2-ThioUTP tetrasodium salt |
| Potent and selective P2Y2 agonist | |
| 7122 | Thioflavin T |
| Cell-permeable fluorescent amyloid stain. Used for: in vitro Aβ staining in brain tissues. | |
| 0644 | Thioperamide |
| H3 antagonist; also H4 inverse agonist | |
| 3070 | Thioridazine hydrochloride |
| Dopamine receptor antagonist; antipsychotic | |
| 7005 | 4-Thiouridine |
| Photoreactive uridine analog for RNA sequencing | |
| 1185 | Thrombin Receptor Agonist Peptide |
| Causes platelet aggregation and secretion | |
| 4256 | Tiagabine hydrochloride |
| Selective GAT-1 inhibitor; anticonvulsant | |
| 5579 | Tilfrinib |
| Potent and selective breast tumor kinase (Brk) inhibitor | |
| 0826 | Tiotidine |
| Potent and selective H2 antagonist | |
| 5902 | Tiotropium bromide |
| Potent muscarinic receptor antagonist | |
| 5565 | Tiplaxtinin |
| Plasminogen activator inhibitor-1 (PAI-1) inhibitor | |
| 7389 | Tissue Clearing Pro |
| Tissue clearing reagent kit | |
| 7563 | Tissue Clearing Pro Reagent 1 |
| Tissue clearing reagent | |
| 7390 | Tissue Clearing Pro-Organoid |
| 3D cell culture clearing reagent kit | |
| 3609 | Tizanidine hydrochloride |
| α2 agonist | |
| 2540 | Tocrifluor T1117 |
| Fluorescent cannabinoid ligand; fluorescent form of AM 251 (Cat. No. 1117) | |
| 7152 | Tocriscreen 2.0 Micro |
| Bioactive compound library for high-throughput screening, high-content screening, target validation and assay development; comprised of 1280 biologically active compounds (15 μL 10 mM DMSO solutions) | |
| 8100 | Tocriscreen GPCR Compound Library |
| A bioactive compound library of 240 GPCR compounds (100 μL 10 mM DMSO solutions) for high-throughput screening, high-content screening, target validation and assay development | |
| 7340 | Tocriscreen Stem Cell Library |
| A library of 120 stem cell compounds (100 μL 10 mM DMSO solutions) to explore stem cell reprogramming, differentiation, proliferation and signaling | |
| 6555 | TokeOni |
| NIR-emission luciferin analog; ideal for deep tissue applications; orally bioavailable and brain penetrant | |
| 5864 | Tolcapone |
| COMT inhibitor; also inhibits transthyretin aggregation | |
| 5181 | Tolvaptan |
| Potent and selective vasopressin V2 receptor antagonist; renoprotective and orally active | |
| 2011 | Tomoxetine hydrochloride |
| Potent and selective noradrenalin re-uptake inhibitor | |
| 3620 | Topiramate |
| GluK1 antagonist; inhibits carbonic anhydrase (CA) II and IV; also positive allosteric modulator of GABAA receptors | |
| 4247 | Torin 1 |
| Potent and selective mTOR inhibitor | |
| 4248 | Torin 2 |
| Potent and selective mTOR inhibitor | |
| 5270 | Toyocamycin |
| Adenosine analog; antifungal antibiotic | |
| 7709 | Trametinib |
| Potent and selective MEK inhibitor; orally bioavailable | |
| 1098 | Tranilast |
| Antiallergic; inhibits inflammatory mediator release from mast cells | |
| 8829 | TransMoDE 3 Biotin New |
| Biotinylated angiopep-2, induces internalization and degradation of streptavidin in brain cell lines | |
| 3852 | Tranylcypromine hydrochloride |
| Irreversible inhibitor of LSD1; also inhibits MAO | |
| 5349 | Treprostinil |
| Potent prostacyclin (PGI2) analog | |
| 2337 | Trequinsin hydrochloride |
| Highly potent PDE3 inhibitor | |
| 2472 | Triacsin C |
| Inhibitor of acyl-CoA synthetase | |
| 1406 | Trichostatin A |
| Potent histone deacetylase inhibitor | |
| 7814 | Tricyclic cytosine tC |
| Fluorescent tricyclic cytosine analog for RNA imaging | |
| 3253 | Triptolide |
| Inhibits RNAPII-mediated transcription; antitumor, anti-inflammatory and immunosuppressive | |
| 2191 | S-Trityl-L-cysteine |
| Potent, selective inhibitor of mitotic kinesin Eg5 | |
| 7937 | Trofinetide |
| IGF-1 synthetic analogue | |
| 3114 | Troglitazone |
| Selective PPARγ agonist; antidiabetic agent | |
| 6002 | Trolox |
| Antifade reagent; antioxidant vitamin E derivative; cell permeable and water soluble | |
| 2459 | Tropisetron hydrochloride |
| Potent 5-HT3 antagonist; also α7 nAChR partial agonist | |
| 3863 | Trovafloxacin mesylate |
| Antibiotic; inhibits bacterial DNA synthesis | |
| 3402 | Tubacin |
| HDAC6 inhibitor; inhibits α-tubulin deacetylation | |
| 2820 | (+)-Tubocurarine chloride |
| nAChR antagonist | |
| 7640 | Tucatinib |
| Potent and selective ErbB2 inhibitor | |
| 3516 | Tunicamycin |
| Antibiotic; GlcNAc phosphotransferase inhibitor |
Tocris Products by Catalog Number
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900